Bahrain healthcare market: size, growth and outlook 2026–2032

A small, insured, fast-privatising market with a new national health insurance scheme. Published estimates normalised to 2025 range from USD 2.3 bn to USD 2.6 bn; the Consulting Wallah central estimate is USD 2.5 bn, growing at about 6% a year to USD 3.6 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by mandatory health insurance for expatriates effective 1 Nov 2026, shifting ~850k expats from Salmaniya to private providers; universal public coverage via Sehati and National Health Plan 2016-2025 reforms; rising NCD burden (22.1% diabetes, CVD ~53.8% of deaths).

Context that matters for buyers and suppliers: Bahrain has 924 licensed healthcare facilities, 877 of them private. Salmaniya Medical Complex (est. 1957) has ~1,200 beds and 900-1,000 daily admissions. American Mission Hospital was established in 1893. Non-Bahrainis are 848,934 of 1,588,670 residents (~53%).

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 2.3 bn–USD 2.6 bn; differences are mostly scope.

Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product sales, insurance premiums and health IT (covered in separate reports). Published totals differ mainly by whether products and insurance are folded in.

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• Bahrain has 924 licensed healthcare facilities, 877 of them private (Nexdigm)
• Salmaniya Medical Complex (est. 1957) has ~1,200 beds and 900-1,000 daily admissions (Nexdigm)
• American Mission Hospital was established in 1893 (Nexdigm)
• Non-Bahrainis are 848,934 of 1,588,670 residents (~53%) (Nexdigm)
• Sehati trial run (2023) earmarked 11 hospitals and 27 health centres (GDN Online)
• Government Hospitals operates 8 hospitals; ~28 primary health centres handle primary care (News of Bahrain)
• Cardiovascular diseases account for ~53.8% of deaths; NCDs ~75% of mortality (MarkNtel Advisors)
• Bahrain market grew from USD 1.8 bn to USD 2.4 bn (Nexdigm) (Nexdigm)

Where the GCC and India sit

• Licensed healthcare facilities: 924 licensed facilities, of which 877 private (2024) — Nexdigm
• Salmaniya Medical Complex: ~1,200 beds; 900-1,000 daily admissions (2024) — Nexdigm
• Public primary care: 26-28 primary health centres; Government Hospitals runs 8 hospitals (2026) — Nexdigm; News of Bahrain
• Population: 1,588,670 residents incl. 848,934 non-Bahrainis; 61,218 aged 65+; life expectancy 81.3 (2024) — Nexdigm
• Workforce density: 0.842 physicians and 2.346 nurses/midwives per 1,000 (World Bank series) — Nexdigm
• Foreign worker permits: 631,763 active permits end-Q2; 33,740 new permits in quarter (2025) — Nexdigm

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: private hospital and clinic capacity to absorb expatriate demand post Nov 2026 mandatory insurance; pharmaceutical localisation and proposed dedicated manufacturing zone; duty-free raw material imports; regional supply, logistics and re-export hub for GCC pharma/devices.

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Operators and investors: capacity, payer rules and licensing timelines decide returns; design central procurement and insurer contracting into the operating model before opening.
• Suppliers: registration, a local partner and payer-formulary presence are the gates; central tenders reward structured quotations and reliable supply over the lowest price.
• Hospital leaders: payer pressure makes the 25–35% of cost in supplies the margin lever — see the free executive assessment.

1. Nexdigm, Bahrain Healthcare Market Report — nexdigm.com
2. MarkNtel Advisors, Bahrain Healthcare Market Research Report 2026-2032 — marknteladvisors.com
3. News of Bahrain, Expats to Shift from Salmaniya to Private Hospitals — newsofbahrain.com
4. GDN Online, Gearing up for Sehati trial run — gdnonline.com
5. Ken Research, Bahrain Hospital Services Market 2025-2030 — kenresearch.com
6. Nexdigm (2025-07) — USD 2.4 bn (up from USD 1.8 bn in prior years) (2024) to — (2030), CAGR —; scope: country - Bahrain healthcare market / health expenditure (care settings and payers); forecast 2025-2030 figures not shown publicly — source
7. MarkNtel Advisors (2026-04) — USD 2.30 bn (2026E: USD 2.36 bn) (2025) to USD 2.85 bn (2032), CAGR 5.26% (2026-2032); scope: country - Bahrain healthcare market (expenditure, pharma, devices, insurance, workforce) — source
8. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
9. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.